DK1180020T4 - Poröse lægemiddelmatrixer og fremgangsmåder til fremstilling deraf - Google Patents

Poröse lægemiddelmatrixer og fremgangsmåder til fremstilling deraf

Info

Publication number: DK1180020T4
Authority: DK; Denmark
Prior art keywords: drug; porous matrix; forming agent; pore forming; volatile
Prior art date: 1999-05-27

Application number

DK00939365T

Other languages

English (en)

Other versions

DK1180020T3 (da

Inventor

Julie Straub

Howard Bernstein

Donald E Chickering Iii

Sarwat Khatak

Greg Randall

Original Assignee

Acusphere Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-05-27

Filing date

2000-05-25

Publication date

2009-10-05

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27495210&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1180020(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-11-04 Priority claimed from US09/433,486 external-priority patent/US6395300B1/en

2000-05-25 Application filed by Acusphere Inc filed Critical Acusphere Inc

2006-03-27 Publication of DK1180020T3 publication Critical patent/DK1180020T3/da

2009-10-05 Application granted granted Critical

2009-10-05 Publication of DK1180020T4 publication Critical patent/DK1180020T4/da

Links

229940079593 drug Drugs 0.000 title abstract 14
239000003814 drug Substances 0.000 title abstract 14
238000000034 method Methods 0.000 title abstract 2
239000011159 matrix material Substances 0.000 abstract 7
239000002904 solvent Substances 0.000 abstract 5
239000003795 chemical substances by application Substances 0.000 abstract 4
239000011148 porous material Substances 0.000 abstract 4
ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 abstract 2
229930012538 Paclitaxel Natural products 0.000 abstract 2
239000012736 aqueous medium Substances 0.000 abstract 2
239000002775 capsule Substances 0.000 abstract 2
238000004090 dissolution Methods 0.000 abstract 2
229960003668 docetaxel Drugs 0.000 abstract 2
239000000839 emulsion Substances 0.000 abstract 2
239000011859 microparticle Substances 0.000 abstract 2
229960001592 paclitaxel Drugs 0.000 abstract 2
238000010561 standard procedure Methods 0.000 abstract 2
239000000725 suspension Substances 0.000 abstract 2
RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 1
239000003684 drug solvent Substances 0.000 abstract 1
239000007788 liquid Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000007787 solid Substances 0.000 abstract 1
238000001694 spray drying Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Materials For Medical Uses (AREA)
Epoxy Compounds (AREA)

DK00939365T 1999-05-27 2000-05-25 Poröse lægemiddelmatrixer og fremgangsmåder til fremstilling deraf DK1180020T4 (da)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US13632399P	1999-05-27	1999-05-27
US15865999P	1999-10-08	1999-10-08
US09/433,486 US6395300B1 (en)	1999-05-27	1999-11-04	Porous drug matrices and methods of manufacture thereof
US18631000P	2000-03-02	2000-03-02
PCT/US2000/014578 WO2000072827A2 (en)	1999-05-27	2000-05-25	Porous drug matrices and methods of manufacture thereof

Publications (2)

Publication Number	Publication Date
DK1180020T3 DK1180020T3 (da)	2006-03-27
DK1180020T4 true DK1180020T4 (da)	2009-10-05

Family

ID=27495210

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK00939365T DK1180020T4 (da)	1999-05-27	2000-05-25	Poröse lægemiddelmatrixer og fremgangsmåder til fremstilling deraf

Country Status (18)

Country	Link
EP (1)	EP1180020B2 (da)
JP (1)	JP4722295B2 (da)
KR (2)	KR100752000B1 (da)
CN (1)	CN1240373C (da)
AT (1)	ATE312601T1 (da)
AU (1)	AU768022B2 (da)
BR (1)	BR0010984A (da)
CA (1)	CA2371836C (da)
DE (1)	DE60024811T3 (da)
DK (1)	DK1180020T4 (da)
ES (1)	ES2250141T5 (da)
HK (1)	HK1048956B (da)
IL (2)	IL146659A0 (da)
MX (1)	MXPA01012106A (da)
NO (1)	NO323761B1 (da)
NZ (1)	NZ516083A (da)
TW (1)	TWI274589B (da)
WO (1)	WO2000072827A2 (da)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6342533B1 (en)	1998-12-01	2002-01-29	Sepracor, Inc.	Derivatives of (−)-venlafaxine and methods of preparing and using the same
DE60039132D1 (de)	1999-04-06	2008-07-17	Sepracor Inc	O-Desmethylvenlafaxin-Succinat
US8771740B2 (en) *	1999-12-20	2014-07-08	Nicholas J. Kerkhof	Process for producing nanoparticles by spray drying
AR035642A1 (es)	2000-05-26	2004-06-23	Pharmacia Corp	Uso de una composicion de celecoxib para el alivio rapido del dolor
US6589557B2 (en) *	2000-06-15	2003-07-08	Acusphere, Inc.	Porous celecoxib matrices and methods of manufacture thereof
US6613308B2 (en) *	2000-09-19	2003-09-02	Advanced Inhalation Research, Inc.	Pulmonary delivery in treating disorders of the central nervous system
US6514482B1 (en)	2000-09-19	2003-02-04	Advanced Inhalation Research, Inc.	Pulmonary delivery in treating disorders of the central nervous system
DE10059020A1 (de) *	2000-11-28	2002-05-29	Gruenenthal Gmbh	Parenteral applizierbare Darreichungsformen
CA2432319A1 (en)	2000-12-21	2002-07-18	Nektar Therapeutics	Pulmonary delivery of polyene antifungal agents
WO2002064132A2 (en) *	2001-01-18	2002-08-22	Pharmacia & Upjohn Company	Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
US7115565B2 (en)	2001-01-18	2006-10-03	Pharmacia & Upjohn Company	Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
EP1864967A1 (en) †	2001-02-12	2007-12-12	Wyeth	Method for preparing O-desmethyl-venlafaxine
US7458374B2 (en)	2002-05-13	2008-12-02	Alexza Pharmaceuticals, Inc.	Method and apparatus for vaporizing a compound
US7766013B2 (en)	2001-06-05	2010-08-03	Alexza Pharmaceuticals, Inc.	Aerosol generating method and device
US7585493B2 (en)	2001-05-24	2009-09-08	Alexza Pharmaceuticals, Inc.	Thin-film drug delivery article and method of use
US20070122353A1 (en)	2001-05-24	2007-05-31	Hale Ron L	Drug condensation aerosols and kits
WO2002094231A1 (en) *	2001-05-24	2002-11-28	Alexza Molecular Delivery Corporation	Delivery of analgesics through an inhalation route
US7090830B2 (en)	2001-05-24	2006-08-15	Alexza Pharmaceuticals, Inc.	Drug condensation aerosols and kits
CA2446904A1 (en)	2001-05-24	2003-04-03	Alexza Pharmaceuticals, Inc.	Delivery of drug esters through an inhalation route
WO2003007968A1 (en) *	2001-07-17	2003-01-30	Sun Pharmaceutical Industries Ltd.	A cardiotonic composition
WO2003041693A1 (en)	2001-11-09	2003-05-22	Alexza Molecular Delivery Corporation	Delivery of diazepam through an inhalation route
US7005138B2 (en) *	2001-12-21	2006-02-28	Duramed Pharmaceuticals, Inc.	Method of systematically delivering SSRIs
JP4384503B2 (ja) *	2002-03-20	2009-12-16	アルカーメス，インコーポレイテッド	レボドパの肺送達
JP4452970B2 (ja) *	2002-03-27	2010-04-21	日本臓器製薬株式会社	ジクロフェナクナトリウム経口製剤
US9060941B2 (en)	2002-09-20	2015-06-23	Actavis, Inc.	Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7959946B2 (en)	2002-09-20	2011-06-14	Watson Pharmaceuticals, Inc.	Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7785627B2 (en)	2002-09-20	2010-08-31	Watson Pharmaceuticals, Inc.	Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US8084058B2 (en)	2002-09-20	2011-12-27	Watson Pharmaceuticals, Inc.	Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US8980870B2 (en)	2002-09-24	2015-03-17	Boehringer Ingelheim International Gmbh	Solid telmisartan pharmaceutical formulations
WO2004030659A1 (en) *	2002-09-30	2004-04-15	Acusphere, Inc.	Sustained release porous microparticles for inhalation
SI1610791T1 (sl)	2003-03-31	2011-05-31	Titan Pharmaceuticals Inc	Implantibilna polimerna naprava za zadrĹľano sproĹˇÄŤanje dopaminskega agonista
US7276246B2 (en)	2003-05-09	2007-10-02	Cephalon, Inc.	Dissolvable backing layer for use with a transmucosal delivery device
US7306812B2 (en)	2003-05-09	2007-12-11	Cephalon, Inc.	Dissolvable backing layer for use with a transmucosal delivery device
EP1625333A1 (en)	2003-05-21	2006-02-15	Alexza Pharmaceuticals, Inc.	Self-contained heating unit and drug-supply unit employing same
GB0401947D0 (en)	2004-01-28	2004-03-03	Unilever Plc	Porous bodies and method of production thereof
KR100681660B1 (ko) *	2004-03-17	2007-02-09	주식회사종근당	방출제어 펠릿의 약제학적 조성물
US7540286B2 (en)	2004-06-03	2009-06-02	Alexza Pharmaceuticals, Inc.	Multiple dose condensation aerosol devices and methods of forming condensation aerosols
EP2246086A3 (en)	2004-08-12	2012-11-21	Alexza Pharmaceuticals, Inc.	Aerosol drug delivery device incorporating percussively activated heating unit
GB0425758D0 (en)	2004-11-23	2004-12-22	Vectura Ltd	Preparation of pharmaceutical compositions
EP1681056A1 (en) *	2005-01-14	2006-07-19	Krka Tovarna Zdravil, D.D., Novo Mesto	Process for preparing lansoprazole
CA2613875C (en) *	2005-07-04	2018-09-25	Ramu Krishnan	Improved drug or pharmaceutical compounds and a preparation thereof
GB0517688D0 (en) *	2005-08-31	2005-10-05	Cambridge Biostability Ltd	Improvements in the stabilisation of biological materials
GB0523638D0 (en)	2005-11-21	2005-12-28	Cambridge Biostability Ltd	Pharmaceutical device for the administration of substances to patients
AR054215A1 (es) *	2006-01-20	2007-06-13	Eriochem Sa	Una formulacion farmaceutica de un taxano, una composicion solida de un taxano liofilizado a partir de una solucion de acido acetico, un procedimiento para la preparacion de dicha composicion solida de un taxano, una composicion solubilizante de un taxano liofilizado, y un conjunto de elementos (kit
JP2009524646A (ja) *	2006-01-27	2009-07-02	ザ・プロヴォスト，フェローズ・アンド・スカラーズ・オブ・ザ・カレッジ・オブ・ザ・ホーリー・アンド・アンディヴァイデッド・トリニティー・オブ・クイーン・エリザベス，ニア・ダブリン	多孔性微粒子の製造方法
KR100917809B1 (ko)	2006-05-22	2009-09-18	에스케이케미칼주식회사	우수한 저장안정성을 갖는 도세탁셀 함유 주사제 조성물
GB0613925D0 (en) *	2006-07-13	2006-08-23	Unilever Plc	Improvements relating to nanodispersions
EP2121088B1 (en)	2007-03-09	2016-07-13	Alexza Pharmaceuticals, Inc.	Heating unit for use in a drug delivery device
MX2009011641A (es)	2007-04-27	2010-03-04	Endo Pharmaceuticals Solutions	Agentes de liberacion para dispositivo de implante y metodos para utilizar los mismos.
PT103743B (pt) *	2007-05-16	2013-01-15	Hovione Farmaciencia S A	Processo para preparar derivados de 21-disódio fosfato de pregnanos.
MX2010002179A (es)	2007-08-24	2010-04-27	Stichting Het Nl Kanker I	Composicion para el tratamiento de enfermedades neoplasicas.
GB0716591D0 (en) *	2007-08-24	2007-10-03	Vereniging Het Nl Kanker I	Composition
EP2197416A1 (en) *	2007-10-09	2010-06-23	Novartis Ag	Pharmaceutical formulation of valsartan
US9801818B2 (en)	2007-12-31	2017-10-31	Samyang Biopharmaceuticals Corporation	Method for stabilizing amphiphilic block copolymer micelle composition containing poorly water-soluble drug
KR101024742B1 (ko) *	2007-12-31	2011-03-24	주식회사 삼양사	탁산 함유 양친성 블록 공중합체 미셀 조성물 및 그 제조방법
AU2009273747A1 (en) *	2008-07-25	2010-01-28	Alphapharm Pty Ltd	Atovaquone with a particle size diameter range (D90) of greater than 3 um to about 10 um
JP2012500788A (ja) *	2008-08-22	2012-01-12	スティヒティングヘットネーデルランドカンケルインスティテュート	組成物
WO2010102065A1 (en)	2009-03-05	2010-09-10	Bend Research, Inc.	Pharmaceutical compositions of dextran polymer derivatives
WO2010111132A2 (en)	2009-03-27	2010-09-30	Bend Research, Inc.	Spray-drying process
PT2611530T (pt)	2010-09-03	2019-05-09	Bend Res Inc	Aparelho de secagem por pulverização e métodos de utilização do mesmo
US9084976B2 (en)	2010-09-03	2015-07-21	Bend Research, Inc.	Spray-drying apparatus and methods of using the same
WO2012040502A1 (en)	2010-09-24	2012-03-29	Bend Research, Inc.	High-temperature spray drying process and apparatus
EP2678320B1 (en)	2011-02-23	2018-09-19	Coeruleus Ltd.	Flumazenil complexes, compositions comprising same and uses thereof
US9084727B2 (en)	2011-05-10	2015-07-21	Bend Research, Inc.	Methods and compositions for maintaining active agents in intra-articular spaces
CN103301095B (zh) *	2012-03-13	2016-04-13	中国科学院上海药物研究所	一种用于提高普罗布考口服吸收的多孔复合载药组合物及其制备方法
US20150150788A1 (en) *	2012-06-22	2015-06-04	The University Of Queensland	Method and composition for delivering a compound through a biological barrier
US20160317542A1 (en)	2013-12-09	2016-11-03	Respira Therapeutics, Inc.	Pde5 inhibitor powder formulations and methods relating thereto
US11464741B2 (en)	2014-06-11	2022-10-11	SpecGx LLC	Spray dried compositions having different dissolution profiles and processes for their preparation
WO2016067132A1 (en)	2014-10-31	2016-05-06	Bend Research Inc.	Process for forming active domains dispersed in a matrix
CN107205938A (zh) *	2014-12-18	2017-09-26	温德加普医疗股份有限公司	用于溶解或增溶治疗剂的方法和组合物
EP3302423B1 (en) *	2015-06-04	2022-05-25	Crititech, Inc.	Particle production system and particle collection device
CA2998483C (en)	2015-09-16	2022-09-06	Dfb Soria, Llc	Delivery of drug nanoparticles and methods of use thereof
BR112018069628A2 (pt) *	2016-04-04	2019-02-12	Crititech, Inc.	métodos para tratamento de tumor sólido
US10076494B2 (en)	2016-06-16	2018-09-18	Dexcel Pharma Technologies Ltd.	Stable orally disintegrating pharmaceutical compositions
KR101965708B1 (ko) *	2016-08-30	2019-04-04	이화여자대학교 산학협력단	스폰지 유사 구조를 갖는 고분자 미립자 및 이의 제조방법
WO2018170196A1 (en)	2017-03-15	2018-09-20	Dfb Soria, Llc	Topical therapy for the treatment of skin malignancies using nanoparticles of taxanes
EP3615145B1 (en)	2017-06-09	2024-05-15	Crititech, Inc.	Compositions for use in the treatment of epithelial cysts by intracystic injection of antineoplastic particles
WO2018231908A1 (en)	2017-06-14	2018-12-20	Crititech, Inc.	Methods for treating lung disorders
KR20250057947A (ko)	2017-10-03	2025-04-29	크리티테크, 인크.	암의 치료를 위한 면역치료제의 전신 전달과 조합된 항신생물성 입자의 국소 전달
US11278492B2 (en)	2018-01-05	2022-03-22	Impel Neuropharma, Inc.	Intranasal delivery of olanzapine by precision olfactory device
EP3746138B1 (en)	2018-02-02	2025-12-10	Alexza Pharmaceuticals, Inc.	Electrical condensation aerosol device
US11497726B2 (en)	2018-03-16	2022-11-15	Dfb Soria, Ll.	Topical therapy for the treatment of cervical intraepithelial neoplasia (CIN) and cervical cancer using nanoparticles of taxanes
AU2020216278B2 (en)	2019-01-29	2025-09-04	Bayer Healthcare Llc	Topical gel compositions of naproxen
WO2020227816A1 (en) *	2019-05-10	2020-11-19	Anomera Inc.	Porous cellulose microparticles and methods of manufacture thereof
EP4477215A3 (en)	2020-12-08	2025-02-19	Ruminant Biotech Corp Limited	Improvements to devices and methods for delivery of substances to animals
CN113081971A (zh) *	2021-05-14	2021-07-09	江西中医药大学	一种中药多孔核壳型复合粒子粉体及其制备方法和应用
CN117538462B (zh) *	2024-01-10	2024-03-26	地奥集团成都药业股份有限公司	一种氨氯地平贝那普利胶囊有关物质的检测方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1265615A (da) *	1970-09-10	1972-03-01
NL7313626A (nl) †	1973-10-04	1975-04-08	Philips Nv	Gecombineerde inrichting voor het produceren en sselen van warmte met een warmte ver- ende inrichting.
GB8322007D0 (en) †	1983-08-16	1983-09-21	Wellcome Found	Pharmaceutical delivery system
IL82245A (en) *	1986-04-25	1990-07-26	Basf Ag	Preparation of spray-dried granules of active ingredients
EP0655237A1 (de) *	1993-11-27	1995-05-31	Hoechst Aktiengesellschaft	Medizinische Aerosolformulierung
US5762961A (en) *	1996-02-09	1998-06-09	Quadrant Holdings Cambridge Ltd.	Rapidly soluble oral solid dosage forms, methods of making same, and compositions thereof
DE69732306T2 (de) *	1997-01-16	2006-01-12	Massachusetts Institute Of Technology, Cambridge	Zubereitung von partikelhaltigen arzneimitteln zur inhalation
CN1169520C (zh) *	1997-09-29	2004-10-06	耐科塔医药公司	多孔微粒及其使用方法
JP4758525B2 (ja) *	1998-03-20	2011-08-31	武田薬品工業株式会社	生理活性ポリペプチドの徐放性製剤およびその製造法
US6423345B2 (en) †	1998-04-30	2002-07-23	Acusphere, Inc.	Matrices formed of polymer and hydrophobic compounds for use in drug delivery

2000
- 2000-05-25 CA CA002371836A patent/CA2371836C/en not_active Expired - Fee Related
- 2000-05-25 KR KR1020017015052A patent/KR100752000B1/ko not_active Expired - Fee Related
- 2000-05-25 AU AU54459/00A patent/AU768022B2/en not_active Ceased
- 2000-05-25 NZ NZ516083A patent/NZ516083A/en not_active IP Right Cessation
- 2000-05-25 DK DK00939365T patent/DK1180020T4/da active
- 2000-05-25 EP EP00939365A patent/EP1180020B2/en not_active Expired - Lifetime
- 2000-05-25 HK HK03101310.8A patent/HK1048956B/zh not_active IP Right Cessation
- 2000-05-25 AT AT00939365T patent/ATE312601T1/de active
- 2000-05-25 DE DE60024811T patent/DE60024811T3/de not_active Expired - Lifetime
- 2000-05-25 CN CNB008081611A patent/CN1240373C/zh not_active Expired - Fee Related
- 2000-05-25 WO PCT/US2000/014578 patent/WO2000072827A2/en not_active Ceased
- 2000-05-25 BR BR0010984-3A patent/BR0010984A/pt not_active IP Right Cessation
- 2000-05-25 ES ES00939365T patent/ES2250141T5/es not_active Expired - Lifetime
- 2000-05-25 IL IL14665900A patent/IL146659A0/xx unknown
- 2000-05-25 KR KR1020077012286A patent/KR100883477B1/ko not_active Expired - Fee Related
- 2000-05-25 JP JP2000620939A patent/JP4722295B2/ja not_active Expired - Fee Related
- 2000-05-25 MX MXPA01012106A patent/MXPA01012106A/es active IP Right Grant
- 2000-05-29 TW TW089110363A patent/TWI274589B/zh not_active IP Right Cessation
2001
- 2001-11-21 IL IL146659A patent/IL146659A/en not_active IP Right Cessation
- 2001-11-26 NO NO20015753A patent/NO323761B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
TWI274589B (en)	2007-03-01
ES2250141T3 (es)	2006-04-16
NZ516083A (en)	2003-08-29
DK1180020T3 (da)	2006-03-27
EP1180020A2 (en)	2002-02-20
JP2003500438A (ja)	2003-01-07
HK1048956B (zh)	2006-07-28
ATE312601T1 (de)	2005-12-15
KR100752000B1 (ko)	2007-08-28
BR0010984A (pt)	2002-04-30
KR100883477B1 (ko)	2009-02-16
CN1365274A (zh)	2002-08-21
ES2250141T5 (es)	2009-11-05
CA2371836C (en)	2006-01-31
DE60024811T2 (de)	2006-09-14
HK1048956A1 (en)	2003-04-25
HK1094775A1 (zh)	2007-04-13
EP1180020B2 (en)	2009-06-24
AU768022B2 (en)	2003-11-27
MXPA01012106A (es)	2003-06-30
NO20015753L (no)	2002-01-28
CN1240373C (zh)	2006-02-08
DE60024811D1 (de)	2006-01-19
KR20070069219A (ko)	2007-07-02
AU5445900A (en)	2000-12-18
JP4722295B2 (ja)	2011-07-13
WO2000072827A3 (en)	2001-01-25
KR20020011992A (ko)	2002-02-09
WO2000072827A2 (en)	2000-12-07
WO2000072827A9 (en)	2002-01-31
EP1180020B1 (en)	2005-12-14
NO323761B1 (no)	2007-07-02
CA2371836A1 (en)	2000-12-07
DE60024811T3 (de)	2010-01-07
IL146659A (en)	2010-05-31
IL146659A0 (en)	2002-07-25
NO20015753D0 (no)	2001-11-26

Publication	Publication Date	Title
DK1180020T3 (da)	2006-03-27	Poröse lægemiddelmatrixer og fremgangsmåder til fremstilling deraf
RU2420290C2 (ru)	2011-06-10	Твердые, пригодные для орального употребления фармацевтические формы применения, содержащие ривароксабан с модифицированным высвобождением
FI91826C (fi)	1994-08-25	Menetelmä kiinteän valmisteen valmistamiseksi, josta aktiivista yhdistettä vapautuu pidennetyn ajanjakson ajan
DE69812690D1 (de)	2003-04-30	Arzneistoffverabreichungssystem auf basis von flüssigkristall-strukturen
WO2001095877A3 (en)	2002-05-02	Porous celecoxib matrices and methods of manufacture thereof
CO5261593A1 (es)	2003-03-31	Formulaciones de entecavir de dosis bajas y uso
CO5560580A2 (es)	2005-09-30	Formulaciones de sucralosa para disumular sabores desagradables
EA200000154A1 (ru)	2000-10-30	Способ солюбилизации фармацевтически активных ингредиентов в воде и в водных носителях
Sun et al.	2019	A novel enteric positioning osmotic pump capsule-based controlled release system of sinomenine hydrochloride: In vitro and in vivo evaluation
AU2003235156B9 (en)	2003-10-27	Solid dispersion composition
JPS6153214A (ja)	1986-03-17	調節された方法による有効成分の放出を可能にする医薬組成物
ES2310550T3 (es)	2009-01-16	Preparacion liquida acuosa de pranoprofeno.
DK164019B (da)	1992-05-04	Stabiliseret flydende laegemiddelpraeparat indeholdende ioniske laegemidler med protraheret virkning samt fremgangsmaade til fremstilling deraf
Minocha et al.	2019	SOlubility enhancement of poorly water soluble drugs by various techniques
KR100435514B1 (ko)	2004-06-10	실데나필 젖산염의 속효제형
TH78112A (th)	2006-06-22	เนื้อสารยารูพรุน และวิธีการของการผลิตของสิ่งเหล่านั้น
CN100333729C (zh)	2007-08-29	灯盏花素渗透泵控释制剂
KR100981750B1 (ko)	2010-09-10	분무-건조 과립 및 그의 제조방법
JP2616946B2 (ja)	1997-06-04	肝類洞小孔拡張・増加剤
JP5691142B2 (ja)	2015-04-01	ベンズイミダゾール系注射剤
EP0971701B1 (en)	2004-10-20	Method for removing high boiling solvents from drug formulations by vacuum drying
EP0323762A1 (fr)	1989-07-12	Nouvelles compositions anti-tussives et leur procédé d'obtention
Mircia et al.	2008	Study of pentoxifylline chemical stability from modified release tablets with hydrophilic mould
JPH07291863A (ja)	1995-11-07	腎保護作用剤
CN107281294A (zh)	2017-10-24	一种山楂叶总黄酮渗透泵控释片及其制备方法